Form 4: SpringWorks Therapeutics Executive Bhavesh Ashar Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Bhavesh Ashar, Chief Commercial Officer of SpringWorks Therapeutics, reports the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On April 1, 2024, Bhavesh Ashar, Chief Commercial Officer of SpringWorks Therapeutics, Inc. (SWTX), had 1,824 shares of common stock withheld by the issuer to satisfy tax obligations.
- This transaction was related to the vesting of restricted stock units and did not represent a sale by Mr. Ashar.
- Following the transaction, Mr. Ashar beneficially owns 56,330 shares of SpringWorks Therapeutics common stock.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing, indicating standard operational procedures. There is nothing inherently positive or negative, but it reflects ongoing management of executive compensation.
Industry Context
This is a routine filing related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves the withholding of shares for tax purposes, not a sale on the open market.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of stock transaction (tax withholding). |
| 04/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.